Journal
FUTURE VIROLOGY
Volume 5, Issue 6, Pages 785-799Publisher
FUTURE MEDICINE LTD
DOI: 10.2217/FVL.10.55
Keywords
antivirals; Japanese; encephalitis; vaccine
Categories
Funding
- Research on Emerging and Re-emerging Infectious Diseases, the Ministry of Health, Labour and Welfare of Japan [H20-Shinkou-ippan-003]
- Japan Health Sciences Foundation
- Association for Preventive Medicine of Japan
- National Center for Biotechnology Information
- Stanford University, USA
Ask authors/readers for more resources
Japanese encephalitis (JE) is a major public health threat in Asia, because of its high mortality and high incidence of psychoneurological sequelae in survivors. It is caused by JE virus (JEV) infection, transmitted by vector mosquitoes. The disease is vaccine preventable and has been well controlled in some countries. Since no specific antivirals have been approved, prevention with vaccine is important in this disease. This article provides a general overview of JE and JEV, but special focus has been put on recently developed Vero cell-derived formalin-inactivated JE vaccines, and the situation in Japan relating to these vaccines. In Japan, where JE has been well controlled, the strong governmental recommendation of the mouse brain-derived vaccine for routine immunization was suspended in 2005, owing to a patient suffering severe postvaccination events. In 2010, the recommendation was reinstated, targeting a limited population utilizing a Vero cell-derived vaccine.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available